|
Type Species |
(MARV) |
1. |
Almost no antigenic cross-reactivity with Ebola viruses, |
2. |
Virion length is about 790 nm as opposed to 970 nm with Ebola viruses, |
3. |
Genome length of 19.1 kb as opposed to 18.9 kb with Ebola viruses, |
4. |
Single gene overlap as opposed to several overlaps with Ebola viruses, |
5. |
Glycoprotein expression does not involve transcriptional editing of gene four, |
6. |
Protein profile distinct from Ebola viruses; however homogenous for all strains, |
7. |
Glycoprotein gene nulceotide difference of 57% compared with Ebola viruses, |
8. |
Fatality rate in humans is about 25%. |
List of Species Demarcation Criteria in the Genus
Not applicable.
Official virus species names are in italics. Tentative virus species names, alternative names ( ), strains or serotypes are not italicized. Virus names, location and date of isolation ( ), genome sequence accession numbers [ ], and assigned abbreviations ( ) are:
|
Marburg virus |
(MARV) | |
|
Strain Musoke (Kenya, 1980) |
[Z12132] |
|
|
Strain Ratayczak (West Germany, 1967) |
||
|
Strain Popp (West Germany, 1967) |
||
|
Strain Voege (Yugoslavia, 1967) |
||
|
Strain Ozolin (Zimbabwe, 1975) |
||
|
Strain Marburg Ravn (Kenya, 1987) |
Tentative Species in the Genus
None reported.
|
|